Hepi Hari Susapto
Papers
1
Total Citations
15
H-Index
1
About
Dr. Hepi Hari Susapto is a pioneering researcher at the intersection of tissue engineering and cancer biology, with a primary focus on developing advanced 3D bioprinting platforms to model hematological malignancies. His most cited work introduces an automated, robotic multicellular bioprinting system that fabricates a three-dimensional bone marrow niche-like model for acute myeloid leukemia (AML). This innovative approach addresses a critical gap in cancer research—the need for physiologically relevant, reproducible preclinical models that recapitulate the complex bone marrow microenvironment. By precisely controlling the spatial arrangement of multiple cell types, Dr. Susapto’s system enables more accurate studies of AML resistance mechanisms and therapeutic responses. His work has garnered significant attention, with his flagship 2023 paper accumulating 15 citations in a short period, reflecting its immediate impact on the field. Dr. Susapto’s contributions are particularly notable for bridging biofabrication and oncology, offering a powerful tool to reduce reliance on animal models and accelerate the discovery of novel AML therapies. His research holds promise for transforming how scientists study cancer-stroma interactions and test drug efficacy in a human-relevant context.
Research Focus
Key Achievements
Top Papers
- 1